Approval Received for Clinical Study in Romania

This month, an approval was granted by Romanian National Agency for Medicines and Medical Devices to conduct the study in patients with inoperable liver cancers non-responding to standard therapy. Promising research is being carried out by GCT team in Romania and sponsored by a EU based company. The patient enrollment is expected to start shortly following the Investigator Meeting in Bucharest.

GCT has an extensive Oncology expertise in EU, Russia, Ukraine and USA, and this project is another opportunity for the company to enhance it.

Pictured: Monument of Rebirth in front of the MOH building in Bucharest, Romania, image courtesy by Dennis Jarvis under CC BY-SA 2.0

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.